Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Diagnostics firm Beckman Coulter has renewed agreements valued at approximately $94 million per year with MedAssets Supply Chain Systems. Under the terms of the new three-year agreements, MedAssets members will continue to purchase automation, general chemistry, immunoassay, and integrated workcell systems from Beckman Coulter.
Subscribe to our email newsletter
The renewals complement existing agreements for hematology, flow cytometry and coagulation systems, already on contract with MedAssets.
Mary Ellen Kimmeth, MedAssets vice president of laboratory division and capital equipment services, said: “MedAssets provides our members with cost-effective solutions that are critical to their success. Beckman Coulter shares that commitment, offering excellent customer service and a comprehensive range of innovative solutions that enhance our members’ ability to deliver quality patient care.”
Leland Mc Arthy, corporate vice president of North America commercial operations for Beckman Coulter, said: “Our systems simplify and automate laboratory processes, helping to improve the productivity of MedAssets members. And the wide breadth of our products and services meets their diverse testing requirements that help improve patient health and reduce the cost of care.”